Peter Jackson
Management
Good morning, and thank you for joining Jonathan and I for this call. Hopefully, you've all had a chance to watch our presentation this morning, which provides an overview of why the business is well positioned for future growth and details of our 2022 performance. Before we go to questions, I'd just like to touch on a couple of items. As announced in mid-February, we've commenced a consultation with our shareholders in relation to an additional US listing. We outlined in the announcement the numerous long-term strategic as well as capital markets benefits this could yield. One point to emphasize is should we proceed with additional listing, it would not change where we're headquartered domiciled or the taxes we paid. Early feedback from shareholders has been supportive and we'll be meeting many more of our shareholders over the coming weeks. At the end of our process, we'll announce results for shareholder consultation. And until that point there is very little extra we can say. Turning to our 2022 performance. We delivered another strong year. Our US business is going from strength to strength and our advantages are compounding with each new state opening. The recent launches of Maryland and Ohio have been our best yet, providing ever greater – even greater conviction and positive EBITDA for the full year 2023. Outside of the US, the business carries good momentum into 2023. UK and Ireland [ph], the product improvements and efficiency initiatives delivered throughout the year resulted in a strong Q4. Our Australian player volumes remain high as H2 COVID frequency benefit unwind and we saw increased competitive intensity in Q4. The International, our consolidate and invest markets is delivering strong growth and now make up 76% of the division. The division is at a growth inflection point. And when combined with the US profitability in 2023, we'll transform the earnings profile of the business. And with that I'd like to hand it over to Judith for questions.